Posted by Michael Wonder on 02 Apr 2024
Relugolix–estradiol–norethisterone acetate for the treatment of patients with pain associated with endometriosis
28 March 2024 - The Department of Health and Social Care has asked the NICE to produce guidance on the use of relugolix combination therapy in the NHS in England.
Relugolix–estradiol–norethisterone (relugolix combination therapy) is not recommended, within its anticipated marketing authorisation, for treating symptoms of endometriosis in adults who have had medical or surgical treatment for their endometriosis.
